Pneumococcal conjugate second or third-dose vaccines (PCVc) in Philippines
Philippines: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 59.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Philippines, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Philippines stood at 59.0%.
Compared with earlier readings it is up 195.0% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Philippines peaked at 85.0% in 2023 and was at its lowest, 0.0%, in 2008.
That places Philippines 148th out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Philippines, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 35.0% | — |
| 2015 | 20.0% | -42.9% |
| 2016 | 40.0% | +100.0% |
| 2017 | 38.0% | -5.0% |
| 2018 | 49.0% | +28.9% |
| 2019 | 61.0% | +24.5% |
| 2020 | 76.0% | +24.6% |
| 2021 | 61.0% | -19.7% |
| 2022 | 81.0% | +32.8% |
| 2023 | 85.0% | +4.9% |
| 2024 | 59.0% | -30.6% |
| 2025 | 59.0% | +0.0% |
Philippines compared with similar countries
- Philippines's 59.0% is below the median for upper middle income countries, which is 76.0%, 78% of the median. (57 countries reporting)
- Philippines's 59.0% is below the median for East Asia & Pacific, which is 81.0%, 73% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 24.3% | 0.0% | 61.0% | 10 |
| 2020s | 70.2% | 59.0% | 85.0% | 6 |
Countries ranked near Philippines
- 147 North Macedonia 60.0% compare
- 148 Cote d'Ivoire 59.0% compare
- 148 Bolivia 59.0% compare
- 151 Madagascar 56.0% compare
More health data for Philippines
- Un projection of annual infant deaths, annual growth rate -1.24 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5317 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,456 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7,006 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 89 (2025)
- Population ages 00-04, female, annual growth rate -2.61 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.037 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.21 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Philippines?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Philippines was 59.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Philippines?
- The highest recorded value was 85.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Philippines?
- The lowest recorded value was 0.0% in 2008.
- How does Philippines rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Philippines ranks 148th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Philippines?
- Over the last ten years it is up 195.0%. The long-run trend across the full record is volatile.
- Where does this Philippines data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).